BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prahalad P, Zaharieva DP, Addala A, New C, Scheinker D, Desai M, Hood KK, Maahs DM. Improving Clinical Outcomes in Newly Diagnosed Pediatric Type 1 Diabetes: Teamwork, Targets, Technology, and Tight Control-The 4T Study. Front Endocrinol (Lausanne) 2020;11:360. [PMID: 32733375 DOI: 10.3389/fendo.2020.00360] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Chalew S, Delamater AM, Washington S, Bhat J, Franz D, Gomez R, Felipe D, Tieh P, Finger L. Can Innovative Technologies Overcome HbA1c Disparity for African-American Youth with Type 1 Diabetes? J Diabetes Sci Technol 2021;15:1069-75. [PMID: 34137288 DOI: 10.1177/19322968211021386] [Reference Citation Analysis]
2 Tanenbaum ML, Zaharieva DP, Addala A, Ngo J, Prahalad P, Leverenz B, New C, Maahs DM, Hood KK. 'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis. Diabet Med 2021;38:e14567. [PMID: 33772862 DOI: 10.1111/dme.14567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Shang T, Zhang JY, Bequette BW, Raymond JK, Coté G, Sherr JL, Castle J, Pickup J, Pavlovic Y, Espinoza J, Messer LH, Heise T, Mendez CE, Kim S, Ginsberg BH, Masharani U, Galindo RJ, Klonoff DC. Diabetes Technology Meeting 2020. J Diabetes Sci Technol 2021;15:916-60. [PMID: 34196228 DOI: 10.1177/19322968211016480] [Reference Citation Analysis]
4 Divan V, Greenfield M, Morley CP, Weinstock RS. Perceived Burdens and Benefits Associated with Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan. J Diabetes Sci Technol. [DOI: 10.1177/1932296820978769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Addala A, Zaharieva DP, Gu AJ, Prahalad P, Scheinker D, Buckingham B, Hood KK, Maahs DM. Clinically serious hypoglycemia is rare and not associated with time-in-range in youth with new-onset type 1 diabetes. J Clin Endocrinol Metab 2021:dgab522. [PMID: 34265059 DOI: 10.1210/clinem/dgab522] [Reference Citation Analysis]
6 Kompala T, Wong J, Neinstein A. Diabetes Specialists Value CGM Despite Challenges in Prescribing and Data Review Process. J Diabetes Sci Technol 2022;:19322968221088267. [PMID: 35403469 DOI: 10.1177/19322968221088267] [Reference Citation Analysis]
7 Ferstad JO, Vallon JJ, Jun D, Gu A, Vitko A, Morales DP, Leverenz J, Lee MY, Leverenz B, Vasilakis C, Osmanlliu E, Prahalad P, Maahs DM, Johari R, Scheinker D. Population-level management of type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health. Pediatr Diabetes 2021. [PMID: 34374183 DOI: 10.1111/pedi.13256] [Reference Citation Analysis]
8 MacGregor KL, DeMartini KS, Barry-Menkhaus SA, Derr AG, Thompson MJ. The Impact of Integrated Behavioral Healthcare on Glycemic Control. J Clin Psychol Med Settings 2021. [PMID: 34436717 DOI: 10.1007/s10880-021-09817-w] [Reference Citation Analysis]
9 Lee MY, Tanenbaum ML, Maahs DM, Prahalad P, Moore WV. Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action. Case Reports in Endocrinology 2022;2022:1-5. [DOI: 10.1155/2022/9911736] [Reference Citation Analysis]
10 Kompala T, Neinstein AB. Telehealth in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2021;28:21-9. [PMID: 33332927 DOI: 10.1097/MED.0000000000000600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Deeb A, Muammar T, Alsaffar H, Sedaghat S, Al Hassani N, Odeh R, Alkhayyat H, Al Sinani A, Attia N, Adhami S, Elbarbary N. Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes. Diabetes Res Clin Pract 2021;173:108671. [PMID: 33493578 DOI: 10.1016/j.diabres.2021.108671] [Reference Citation Analysis]
12 Tanenbaum ML, Messer LH, Wu CA, Basina M, Buckingham BA, Hessler D, Mulvaney SA, Maahs DM, Hood KK. Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM. Diabetes Res Clin Pract 2021;180:109048. [PMID: 34534592 DOI: 10.1016/j.diabres.2021.109048] [Reference Citation Analysis]
13 Lavens A, Nobels F, De Block C, Oriot P, Verhaegen A, Chao S, Casteels K, Mouraux T, Doggen K, Mathieu C; Belgian Group of Experts IQED and IQECAD. Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World Study. Diabetes Technol Ther 2021;23:565-76. [PMID: 33780640 DOI: 10.1089/dia.2021.0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zaharieva DP, Addala A. Current and Novel Strategies to Reduce Fear of Hypoglycemia as a Barrier to Physical Activity in Adults and Youth With Type 1 Diabetes. Can J Diabetes 2022;46:1-2. [PMID: 35144756 DOI: 10.1016/j.jcjd.2021.12.004] [Reference Citation Analysis]
15 Waizinger O, Shpigelman M, Shental R, Yunis B, Shimoni P, Od Cohen Y, Kagan I. Diabetes nurse practitioners in the shadow of the COVID-19 pandemic: Challenges, insights, and suggestions for improvement. J Nurs Scholarsh 2021. [PMID: 34854227 DOI: 10.1111/jnu.12754] [Reference Citation Analysis]
16 Scheinker D, Gu A, Grossman J, Ward A, Ayerdi O, Miller D, Leverenz J, Hood K, Lee MY, Maahs DM, Prahalad P. Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: A Prospective Evaluation in Clinical Practice (Preprint). JMIR Diabetes. [DOI: 10.2196/27284] [Reference Citation Analysis]
17 Andrikopoulos S, James S, Wischer N. What Gets Measured Gets Improved-Setting Standards and Accreditation for Quality Improvement for Diabetes Services in Australia. J Diabetes Sci Technol 2021;15:748-54. [PMID: 34008432 DOI: 10.1177/19322968211009910] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rose S, Styles SE, Wiltshire EJ, Stanley J, Galland BC, de Bock MI, Tomlinson PA, Rayns JA, MacKenzie KE, Wheeler BJ. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial. Diabet Med 2021;:e14756. [PMID: 34862661 DOI: 10.1111/dme.14756] [Reference Citation Analysis]